Stocks and Investing Stocks and Investing
Fri, January 21, 2022
Thu, January 20, 2022
Wed, January 19, 2022
Tue, January 18, 2022

Steve Scala Maintained (ABBV) at Buy with Increased Target to $150 on, Jan 18th, 2022


Published on 2024-10-27 19:18:30 - WOPRAI, Steve Scala
  Print publication without navigation


Steve Scala of TD Cowen, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $130 to $150 on, Jan 18th, 2022.

Steve has made no other calls on ABBV in the last 4 months.



There are 12 other peers that have a rating on ABBV. Out of the 12 peers that are also analyzing ABBV, 3 agree with Steve's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Initiated at Hold and Held Target at $113 on, Friday, December 17th, 2021
  • Luisa Hector of "Berenberg" Maintained at Hold and Held Target at $105 on, Wednesday, November 24th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $118 on, Monday, November 1st, 2021


These are the ratings of the 9 analyists that currently disagree with Steve


  • Charles Pitman of "Redburn Partners" Initiated at Strong Buy on, Thursday, January 13th, 2022
  • Gary Nachman of "BMO Capital" Maintained at Buy with Increased Target to $153 on, Wednesday, January 12th, 2022
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $154 on, Wednesday, January 5th, 2022
  • Aaron Gal of "Bernstein" Maintained at Buy with Increased Target to $155 on, Monday, January 3rd, 2022
  • Mohit Bansal of "Wells Fargo" Initiated at Buy and Held Target at $165 on, Thursday, December 9th, 2021
  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $129 on, Monday, November 29th, 2021
  • Justin Smith of "Societe Generale" Upgraded from Hold to Strong Buy and Held Target at $172 on, Tuesday, November 23rd, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $124 on, Monday, November 1st, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $135 on, Monday, November 1st, 2021